Results
|
|
2021.
|
|
|
|
2022.
|
|
|
|
2023.
|
|
|
|
2024.
|
|
|
|
2025.
|
|
|
|
2026.
|
|
|
|
2027.
|
|
|
|
2028.
|
|
|
|
2029.
|
|
|
|
2030.
|
|
|
|
2031.
|
|
|
|
2032.
|
Maraviroc, a chemokine receptor-5 antagonist, fails to demonstrate efficacy in the treatment of patients with rheumatoid arthritis in a randomized, double-blind placebo-controlled trial. [electronic resource] by
- Fleishaker, Dona L
- Garcia Meijide, Juan A
- Petrov, Andriy
- Kohen, Michael David
- Wang, Xin
- Menon, Sujatha
- Stock, Thomas C
- Mebus, Charles A
- Goodrich, James M
- Mayer, Howard B
- Zeiher, Bernhardt G
Producer: 20121217
In:
Arthritis research & therapy vol. 14
Availability: No items available.
|
|
|
2033.
|
|
|
|
2034.
|
|
|
|
2035.
|
|
|
|
2036.
|
|
|
|
2037.
|
|
|
|
2038.
|
|
|
|
2039.
|
|
|
|
2040.
|
Household secondhand smoke exposure of elementary schoolchildren in Southern Taiwan and factors associated with their confidence in avoiding exposure: a cross-sectional study. [electronic resource] by
- Huang, Hsiao-Ling
- Yen, Yea-Yin
- Lin, Pi-Li
- Chiu, Chin-Hsuan
- Hsu, Chih-Cheng
- Chen, Ted
- Hu, Chih-Yang
- Lin, Ya-Ying
- Lee, Chien-Hung
- Chen, Fu-Li
Producer: 20120620
In:
BMC public health vol. 12
Availability: No items available.
|